ES449209A1 - Procedimiento de preparacion de derivados pentaciclicos. - Google Patents

Procedimiento de preparacion de derivados pentaciclicos.

Info

Publication number
ES449209A1
ES449209A1 ES449209A ES449209A ES449209A1 ES 449209 A1 ES449209 A1 ES 449209A1 ES 449209 A ES449209 A ES 449209A ES 449209 A ES449209 A ES 449209A ES 449209 A1 ES449209 A1 ES 449209A1
Authority
ES
Spain
Prior art keywords
oxymethano
indoloquinolizines
vasodilating
methano
octahydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES449209A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bpifrance Financement SA
Original Assignee
Agence National de Valorisation de la Recherche ANVAR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agence National de Valorisation de la Recherche ANVAR filed Critical Agence National de Valorisation de la Recherche ANVAR
Publication of ES449209A1 publication Critical patent/ES449209A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C07D211/76—Oxygen atoms attached in position 2 or 6

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ES449209A 1975-06-25 1976-06-25 Procedimiento de preparacion de derivados pentaciclicos. Expired ES449209A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7519960A FR2315277A1 (fr) 1975-06-25 1975-06-25 Nouveaux derives pentacycliques, leur preparation et les compositions qui les contiennent

Publications (1)

Publication Number Publication Date
ES449209A1 true ES449209A1 (es) 1977-07-16

Family

ID=9157046

Family Applications (1)

Application Number Title Priority Date Filing Date
ES449209A Expired ES449209A1 (es) 1975-06-25 1976-06-25 Procedimiento de preparacion de derivados pentaciclicos.

Country Status (17)

Country Link
US (1) US4138489A (es)
JP (1) JPS6039679B2 (es)
AU (1) AU496905B2 (es)
BE (1) BE843215A (es)
CH (1) CH616425A5 (es)
DE (1) DE2627190A1 (es)
DK (1) DK285576A (es)
ES (1) ES449209A1 (es)
FR (1) FR2315277A1 (es)
GB (1) GB1543807A (es)
HU (1) HU174882B (es)
IE (1) IE43138B1 (es)
IL (1) IL49864A0 (es)
LU (1) LU75242A1 (es)
NL (1) NL7606884A (es)
SE (1) SE420730B (es)
ZA (1) ZA763779B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA786426B (en) * 1977-11-25 1979-10-31 Scras New indulo(2,3-a)quinolizidines,preparation and therapeutic use
US4428877A (en) 1978-07-12 1984-01-31 Richter Gedeon Vegyeszeti Gyar Rt. Cis-10-bromo-E-homoeburnanes
JPH0523116Y2 (es) * 1988-07-29 1993-06-14
JP2851133B2 (ja) * 1989-06-21 1999-01-27 リヒター ゲデオン ベジェセティ ジャール アール．テー． 新規ラセミ及び光学的活性オクタヒドロ―インド―ロ〔２，３―ａ〕テトラヒドロピラニル〔２，３―ｃ〕キノリジンジエステル誘導体及びその調製方法
ITRM20010356A1 (it) * 2001-06-21 2002-12-23 Sigma Tau Ind Farmaceuti "5-alogeno derivati della triptamina utili come ligandi del recettore5-ht6 e/o 5-ht7 della serotonina.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536725A (en) * 1967-11-22 1970-10-27 Miles Lab Cyanoethylated derivatives of 2,3,4,6,7,12-hexahydroindolo(2,3-alpha)-quinolizine
FR2168853B1 (es) * 1972-01-24 1975-04-25 Centre Etd Ind Pharma

Also Published As

Publication number Publication date
ZA763779B (en) 1977-06-29
SE7607231L (sv) 1976-12-26
AU496905B2 (en) 1978-11-09
AU1523676A (en) 1978-01-05
BE843215A (fr) 1976-12-21
FR2315277B1 (es) 1979-08-10
FR2315277A1 (fr) 1977-01-21
JPS5217488A (en) 1977-02-09
US4138489A (en) 1979-02-06
IL49864A0 (en) 1976-08-31
LU75242A1 (es) 1978-01-18
DK285576A (da) 1976-12-26
IE43138L (en) 1976-12-25
HU174882B (hu) 1980-04-28
SE420730B (sv) 1981-10-26
JPS6039679B2 (ja) 1985-09-06
IE43138B1 (en) 1980-12-31
DE2627190A1 (de) 1977-01-20
CH616425A5 (es) 1980-03-31
NL7606884A (nl) 1976-12-28
GB1543807A (en) 1979-04-04

Similar Documents

Publication Publication Date Title
ES454162A1 (es) Un procedimiento para la preparacion de nuevos derivados delindol.
AU508160B2 (en) Cyclization
CA1004403A (en) Eye protectors
AU502662B2 (en) N-substituted halo-2-pyrrolidinones
ES452737A1 (es) Un procedimiento para preparar compuestos 2-anol-3-fenilben-zotiofeno.
AU505869B2 (en) Aminoacetyl aniline derivatives
AU503552B2 (en) Azide derivatives of dephalosporins
ES452343A1 (es) Procedimiento para la reticulacion de poliolefinas.
JPS51128983A (en) 3*44dihydrospiroo2hh1*33 benzoxazines
ES449209A1 (es) Procedimiento de preparacion de derivados pentaciclicos.
BE840179A (fr) Forme cristalline d'un antibiotique
ES466590A1 (es) Un procedimiento para la preparacion de derivados de oxadia-zolopirimidina.
ES445763A1 (es) Un procedimiento para la preparacion de derivados de histi- dina.
AU499694B2 (en) N-(1,2,4-triazin-5-on-4-yl)-glycine derivatives
GB1547798A (en) N-(3-2-hydroxypropopyl)-4-methyl-2-oxo-2h-1-benzopyran-7-yl)- carboxamide derivatives
AU509855B2 (en) Compositions of 1, 2, 4-rhiadiazine derivatives
ES411969A1 (es) Procedimiento para la preparacion de una rifamicina 3-sus- tituida.
ES457370A1 (es) Procedimiento de preparacion de nuevos derivados del nafta- leno.
ES460807A1 (es) Procedimiento para la produccion de compuestos de isoindoli-nona.
AU1429676A (en) 5%2,2 dihalovinyl<4,4 dimethyl 2 oxotetrahydrofurans and intermediates
AU504124B2 (en) l-ACYL-l, 2, 3, 4-TETRAHYDRO-6-QUINOLINOLS AND THEIR USE AS ANTIAMEBIC AGENTS
AU509372B2 (en) 2-Phenyl-3-Aroylbenzothiophane Derivatives and their use as Antifertility Agents
AU501305B2 (en) N'sulfonyl-n-dihalophenylimidazolidinedioners
ES462485A1 (es) Procedimiento para la obtencion de amidas-esteres del acido fosforico.
ES471874A1 (es) Procedimiento para la preparacion de nuevos derivados de 1.2.4-triazin-5-ona